Ustekinumab

Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.

Product Specifications

CAS Number

[815610-63-0]

Product Name Alternative

CNTO-1275; L04AC05; TT-20

UNSPSC

12352203

Hazard Statement

H302, H315, H319, H335

Target

Interleukin Related

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Cancer

Assay Protocol

https://www.medchemexpress.com/Ustekinumab.html

Purity

99.83

Solubility

H2O

Smiles

[Ustekinumab]

Molecular Weight

(145.63 kDa)

Precautions

H302, H315, H319, H335

References & Citations

[1]Montepaone M, et al. Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis. Open Access Rheumatol. 2014 Feb 20;6:7-13.|[2]Schoch A, et al. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc Natl Acad Sci U S A. 2015 May 12;112 (19) :5997-6002.